216 related articles for article (PubMed ID: 33511450)
1. Serotonin 5-HT
O'Reilly KC; Connor M; Pierson J; Shuffrey LC; Blakely RD; Ahmari SE; Veenstra-VanderWeele J
Psychopharmacology (Berl); 2021 Apr; 238(4):1111-1120. PubMed ID: 33511450
[TBL] [Abstract][Full Text] [Related]
2. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice.
Shanahan NA; Holick Pierz KA; Masten VL; Waeber C; Ansorge M; Gingrich JA; Geyer MA; Hen R; Dulawa SC
Biol Psychiatry; 2009 Mar; 65(5):401-8. PubMed ID: 19013555
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation.
Woehrle NS; Klenotich SJ; Jamnia N; Ho EV; Dulawa SC
Psychopharmacology (Berl); 2013 Jun; 227(3):545-51. PubMed ID: 23377022
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the roles of β-arrestin2 and GSK-3 signaling in 5-HT1BR-mediated perseverative behavior and prepulse inhibition deficits in mice.
Thompson SL; Dulawa SC
PLoS One; 2019; 14(2):e0211239. PubMed ID: 30721232
[TBL] [Abstract][Full Text] [Related]
5. Clinically effective OCD treatment prevents 5-HT1B receptor-induced repetitive behavior and striatal activation.
Ho EV; Thompson SL; Katzka WR; Sharifi MF; Knowles JA; Dulawa SC
Psychopharmacology (Berl); 2016 Jan; 233(1):57-70. PubMed ID: 26423528
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice.
Dulawa SC; Hen R; Scearce-Levie K; Geyer MA
Ann N Y Acad Sci; 1998 Dec; 861():79-84. PubMed ID: 9928242
[TBL] [Abstract][Full Text] [Related]
7. OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding.
Pittenger C; Adams TG; Gallezot JD; Crowley MJ; Nabulsi N; James Ropchan ; Gao H; Kichuk SA; Simpson R; Billingslea E; Hannestad J; Bloch M; Mayes L; Bhagwagar Z; Carson RE
J Affect Disord; 2016 May; 196():87-96. PubMed ID: 26919057
[TBL] [Abstract][Full Text] [Related]
8. Effects of oxytocin on serotonin 1B agonist-induced autism-like behavior in mice.
Lawson SK; Gray AC; Woehrle NS
Behav Brain Res; 2016 Nov; 314():52-64. PubMed ID: 27439030
[TBL] [Abstract][Full Text] [Related]
9. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
Igari M; Shen HW; Hagino Y; Fukushima S; Kasahara Y; Lesch KP; Murphy DL; Hall FS; Uhl GR; Ikeda K; Yaegashi N; Sora I
Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
[TBL] [Abstract][Full Text] [Related]
10. Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice.
Dulawa SC; Hen R; Scearce-Levie K; Geyer MA
Psychopharmacology (Berl); 1997 Jul; 132(2):125-34. PubMed ID: 9266609
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice.
Montañez S; Munn JL; Owens WA; Horton RE; Daws LC
Neurochem Int; 2014 Jul; 73():127-31. PubMed ID: 24246466
[TBL] [Abstract][Full Text] [Related]
12. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.
Shanahan NA; Velez LP; Masten VL; Dulawa SC
Biol Psychiatry; 2011 Dec; 70(11):1039-48. PubMed ID: 21920503
[TBL] [Abstract][Full Text] [Related]
13. Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment.
Muller CL; Anacker AM; Rogers TD; Goeden N; Keller EH; Forsberg CG; Kerr TM; Wender C; Anderson GM; Stanwood GD; Blakely RD; Bonnin A; Veenstra-VanderWeele J
Neuropsychopharmacology; 2017 Jan; 42(2):427-436. PubMed ID: 27550733
[TBL] [Abstract][Full Text] [Related]
14. 5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes.
Hagan CE; McDevitt RA; Liu Y; Furay AR; Neumaier JF
Synapse; 2012 Dec; 66(12):1024-34. PubMed ID: 22961814
[TBL] [Abstract][Full Text] [Related]
15. Acute serotonin 1B/1A receptor activation impairs behavioral flexibility in C57BL/6J mice.
Oliver BL; Burdette MH; Pahua AE; Cavazos C; Morales CA; Alvarez BD; Amodeo DA
Behav Brain Res; 2022 Jun; 427():113865. PubMed ID: 35367298
[TBL] [Abstract][Full Text] [Related]
16. p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse.
Robson MJ; Quinlan MA; Margolis KG; Gajewski-Kurdziel PA; Veenstra-VanderWeele J; Gershon MD; Watterson DM; Blakely RD
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10245-E10254. PubMed ID: 30297392
[TBL] [Abstract][Full Text] [Related]
17. Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HT₂ receptor activation.
Stancampiano R; Frau R; Bini V; Collu M; Carta M; Fadda F; Bortolato M
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1329-35. PubMed ID: 23141373
[TBL] [Abstract][Full Text] [Related]
18. Rare Opportunities for Insights Into Serotonergic Contributions to Brain and Bowel Disorders: Studies of the SERT Ala56 Mouse.
Stilley SE; Blakely RD
Front Cell Neurosci; 2021; 15():677563. PubMed ID: 34149362
[TBL] [Abstract][Full Text] [Related]
19. Ketamine induces immediate and delayed alterations of OCD-like behavior.
Thompson SL; Welch AC; Iourinets J; Dulawa SC
Psychopharmacology (Berl); 2020 Mar; 237(3):627-638. PubMed ID: 31927606
[TBL] [Abstract][Full Text] [Related]
20.
Quinlan MA; Robson MJ; Ye R; Rose KL; Schey KL; Blakely RD
Front Mol Neurosci; 2020; 13():89. PubMed ID: 32581705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
